The Senior Manager is part of Novo Nordisk’s Global Business Development Search, Evaluation & Intelligence (SE&I) team, which is the primary entry point for external drug and technology opportunities. The team identifies and evaluates external opportunities, supports due diligence and contractual negotiations, and works across Novo Nordisk to advance partnerships and the product portfolio. The role focuses on opportunities in diabetes, obesity, cardiovascular disease, liver disease, rare blood and endocrine disorders, and Consumer Rx. The position contributes to identifying novel pipeline assets and enabling technologies, assessing their fit with therapeutic-area needs and Novo Nordisk’s internal pipeline, and developing detailed therapeutic-area landscapes. It supports technical work throughout the Business Development process, from initial evaluation through due diligence, and helps prepare opportunity presentations and value stories for governance boards and senior management. The role also supports negotiations, alliance-related collaboration, external engagement, and continuous improvement of SE&I processes. The role is part of the global evaluation team, whose members are predominantly located in Denmark and Cambridge, Massachusetts. It reports to the Sr. Director, Global Evaluation, has no direct or indirect reports, and works closely with internal stakeholders across the value chain and Business Development teams, as well as external biotech companies, venture capital firms, and large pharmaceutical companies. The position requires 10–20% overnight travel, which may include international travel.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior